Interactions médicamenteuses
Amikacin + Vancomycin
Gravité: Majeure
Amikacin and Vancomycin: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Both drugs can injure the kidneys, and amikacin also damages the inner ear. Used together they carry a higher rate of acute kidney injury than either alone, and renal decline further raises aminoglycoside levels and ototoxicity risk.
Ce que signifie cette interaction, en termes simples
Amikacin and Vancomycin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Amikacin belongs to Anti Bacterial; Vancomycin belongs to Anti Bacterial.
Pourquoi elle survient
Additive nephrotoxicity from proximal tubular injury, with reduced clearance increasing aminoglycoside exposure.
Conduite à tenir
Avoid the combination where alternatives exist; otherwise monitor serum creatinine frequently and use therapeutic drug monitoring of both drugs. Dose to renal function and consider audiology monitoring for prolonged courses.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Amikacin et Vancomycin, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Vancomycin
- Bacitracin + Vancomycin Majeure
- Capreomycin + Vancomycin Majeure
- Cephaloridine + Vancomycin Majeure
- Cidofovir + Vancomycin Majeure
- Cisplatin + Vancomycin Majeure
- Colistin + Vancomycin Majeure
Autres interactions de Amikacin
- Amikacin + Cidofovir Contre-indiquée
- Adefovir + Amikacin Majeure
- Amikacin + Amphotericin b Majeure
- Amikacin + Amphotericin b deoxycholate Majeure
- Amikacin + Atracurium Majeure
- Amikacin + Bacitracin Majeure
Questions fréquentes
Can I take Amikacin with Vancomycin?
MediHelp rates the interaction as major. Amikacin and Vancomycin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can injure the kidneys, and amikacin also damages the inner ear. Used together they carry a higher rate of acute kidney injury than either alone, and renal decline further raises aminoglycoside levels and ototoxicity risk.
How serious is the interaction between Amikacin and Vancomycin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where alternatives exist; otherwise monitor serum creatinine frequently and use therapeutic drug monitoring of both drugs. Dose to renal function and consider audiology monitoring for prolonged courses.
What other medicines interact with Vancomycin?
MediHelp also lists interactions of Vancomycin with, for example, Bacitracin, Capreomycin, Cephaloridine. The full list is on the Vancomycin page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
